DiaMedica Therapeutics Inc. 8-K

What Happened
DiaMedica Therapeutics Inc. announced (in an 8‑K filed Jan 5, 2026) that on December 19, 2025 it sold 1,501,000 common shares in a block transaction to a healthcare institution fund under its at‑the‑market (ATM) offering program. The shares were sold at $8.10 per share, producing approximately $12.2 million in gross proceeds before fees and expenses.

Key Details

• 1,501,000 common shares sold on December 19, 2025.
• Purchase price: $8.10 per share.
• Gross proceeds: ~$12.2 million (before deducting fees and other expenses).
• Buyer described as a healthcare institution fund; transaction executed as a block sale under the Company’s ATM program.

Why It Matters
This transaction raises near‑term cash for DiaMedica without a public secondary offering process, which can help fund operations, trials or other corporate needs. Investors should note the sale increases the number of outstanding shares (dilution) and that net proceeds will be lower after fees and expenses. The filing does not specify how the company will use the proceeds.